CAMKK2 and prostate cancer: Furthermore, CaMKKβ expression increases with human prostate cancer progression and Gleason score [89,91], and with tumour progression in a transgenic adenocarcinoma of the mouse prostate (TRAMP) mouse model of prostate cancer [89], suggesting that it may also play a role in prostate cancer progression.